Jayasena Hettiarachchi Selected Research

eletriptan (Relpax)

2/2007	Efficacy of eletriptan in triptan-naïve patients: results of a combined analysis.
3/2004	Effectiveness of eletriptan in acute migraine: primary care for Excedrin nonresponders.
2/2004	The 40-mg dose of eletriptan: comparative efficacy and tolerability versus sumatriptan 100 mg.
10/2003	Tolerability and safety of eletriptan in the treatment of migraine: a comprehensive review.
10/2003	Efficacy of eletriptan in migraineurs with persistent poor response to nonsteroidal anti-inflammatory drugs.
7/2003	A cost-effectiveness analysis of eletriptan 40 and 80 mg versus sumatriptan 50 and 100 mg in the acute treatment of migraine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jayasena Hettiarachchi Research Topics

Disease

5	Headache (Headaches) 02/2007 - 07/2003
4	Migraine Disorders (Migraine) 03/2004 - 07/2003
2	Myocardial Ischemia (Ischemic Heart Diseases) 11/2005 - 10/2003
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2005
1	Chest Pain (Chest Pains) 11/2005
1	Nausea 02/2004
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2003

Drug/Important Bio-Agent (IBA)

6	eletriptan (Relpax)FDA Link 02/2007 - 07/2003
4	Pain-FreeIBA 02/2007 - 10/2003
4	Tryptamines (Triptans)IBA 02/2007 - 10/2003
2	Sumatriptan (Imigran)FDA LinkGeneric 02/2004 - 07/2003
1	Nonprescription Drugs (Patent Medicines)IBA 03/2004
1	Cytochrome P-450 CYP3A InhibitorsIBA 10/2003
1	Indicators and Reagents (Reagents)IBA 07/2003

Therapy/Procedure

1	Self Medication 03/2004
1	Therapeutics 10/2003